Cell Therapeutics (CTIC) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cell Therapeutics (CTIC)

An SI Board Since August 1997

Posts	SubjectMarks	Bans	Symbol
946	45	0	CTIC

Emcee: Regis McConnell	Type: Unmoderated

Introduction Market Data Compact

This recent bio-pharmacuetical IPO, has very compelling 'small molecule' technology. Currently in phase II/III trials is a synthetic drug candidate, Lisobylline, for reducing mortality rates related to radiation/chemotherapy treatments.

Here's a link.;-) cticseattle.com

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
946	EMA CHMP gives Pixantrone the thumbs up! >>SEATTLE, Feb. 17, 2012 /PRNews	tuck	-	2/17/2012
945	CTIC up 12% on high volume - what will today bring after this roller coaster wee	trumptowr	-	3/25/2010
944	FDA Raises Concerns About Cell Therapeutics' Cancer Drug By Adam Feuerstein	kenhott	-	2/8/2010
943	The split-adjusted share price is down 99.97% since Feb 2005, which is even wors	DewDiligence_on_SI	-	1/12/2009
942	What gall. By Rami Grunbaum Deputy business editor and Seattle Times Business	Findit	-	1/12/2009
941	DD thnx..	mlkr	-	12/3/2008
940	<i>…yet no move…strange!</i> The explanation can be found here: sil	DewDiligence_on_SI	-	12/2/2008
939	fast review status... made number 1 buy ranked stocks list of ZACK... yet no mov	mlkr	-	12/2/2008
938	Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in	kenhott	-	11/12/2008
937	You mean bonuses are a cash item?	tom pope	-	7/21/2008
936	<i>Cell Therapeutics says it's low on cash</i> Who knew? :-)	DewDiligence_on_SI	-	7/21/2008
935	Cell Therapeutics says it's low on cash Biotechnology company Cell Therapeu	Icebrg	-	7/21/2008
934	CTI's meeting goes without a hitch As I mentioned last week in a story (rea	Icebrg	-	6/21/2008
933	Cell Therapeutics loses equity line of credit In a filing this afternoon, Cell	Icebrg	-	6/21/2008
932	CTI hopes to expand market for Zevalin Hoping to expand the market for its Zeva	Icebrg	-	6/19/2008
931	Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt Mo	Icebrg	-	6/16/2008
930	Cell Therapeutics shareholders mount a revolt. Italians hold the majority stake	Icebrg	-	6/14/2008
929	CTI's Italian shareholders quietly protest At the Cell Therapeutics shareho	Icebrg	-	6/13/2008
928	1,041,000 BUY after close. NEWS coming?	Author51	-	5/28/2008
927	TIME TO BUY!!!!!!!!! BUYINS.NET: CTIC, Has been On BUYINS.NET Naked Short List	Author51	-	5/24/2008
926	CTI hopes to reverse split its stock (again) [Get rid of Bianco would be a much	Icebrg	-	5/10/2008
925	<i>>And today, Cell Therapeutics said that "it had received a posi	DewDiligence_on_SI	-	5/6/2008
924	CTI's troubled Xyotax is now Opaxio Xyotax, Cell Therapeutics' treatmen	Icebrg	-	5/6/2008
923	CTIC-Q Volume exceeds 50-day average volume. 1:52 PM 7/04/2008 Some data dela	Ian@SI	-	4/7/2008
922	Yet another shelf for CTIC: reuters.com They ought to be in the furniture busi	DewDiligence_on_SI	-	3/31/2008

Go to reply# or date (mm/dd/yy):